2026 Q2 Portfolio Activity
In 2026 Q2, Sio Capital Management, LLC maintained a portfolio of 93 distinct positions. The most significant new addition was ALLOGENE THERAPEUTICS INC, now representing 4.59% of the total fund value. They heavily accumulated shares in CENCORA INC, increasing the position by 72.0%. Conversely, Sio Capital Management, LLC completely exited their position in CORCEPT THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
93
Quarter
2026 Q2
Top Holding
AVR (9.0%)
Top 10 Concentration
48.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 93
Sio Capital Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 9.04% | 4.28% |
#1
5
Prev: #6
|
6.1 |
—
|
163,019 | 3.0% |
P
S
|
5,545,984 | $54,627,942 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COR
CENCORA INC
|
Healthcare | 8.13% | 4.55% |
#2
2
Prev: #4
|
7.8 |
—
|
72,694 | 72.0% |
P
S
|
173,588 | $49,121,932 | 2009 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MMS
MAXIMUS INC
|
Industrials | 6.36% | 7.07% |
#3
2
Prev: #1
|
4.0 |
—
|
-53,558 | -7.0% |
P
S
|
715,267 | $38,452,754 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 4.59% | — |
#4
Prev: #—
|
5.8 |
—
|
13,323,431 | — |
NEW
|
13,323,431 | $27,712,736 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMED
GLOBUS MED INC
|
Healthcare | 3.95% | — |
#5
Prev: #—
|
5.6 |
—
|
301,816 | — |
NEW
|
301,816 | $23,846,482 | 2017 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GSK
GSK PLC
|
Healthcare | 3.79% | 3.05% |
#6
5
Prev: #11
|
3.5 |
—
|
50,821 | 13.2% |
P
S
|
436,700 | $22,891,814 | 2014 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 3.68% | 3.33% |
#7
2
Prev: #9
|
3.5 |
—
|
89,876 | 14.8% |
P
S
|
695,315 | $22,208,361 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WAY
WAYSTAR HLDG CO...
|
Healthcare | 3.15% | 5.68% |
#8
6
Prev: #2
|
1.3 |
—
|
-716,402 | -43.6% |
P
S
|
925,834 | $19,007,372 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLS
PUT
SELLAS LIFE SCI...
|
PUT Option | 3.01% | — |
#9
Prev: #—
|
4.7 |
—
|
1,230,700 | — |
NEW
|
1,230,700 | $18,165,132 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 2.96% | — |
#10
Prev: #—
|
4.7 |
—
|
480,383 | — |
NEW
|
480,383 | $17,903,874 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 2.79% | 0.93% |
#11
24
Prev: #35
|
3.6 |
—
|
44,622 | 33.7% |
P
S
|
177,118 | $16,856,320 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CI
THE CIGNA GROUP
|
Healthcare | 2.63% | — |
#12
Prev: #—
|
4.6 |
—
|
57,750 | — |
NEW
|
57,750 | $15,920,520 | 2009 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNY
SANOFI SA
|
Healthcare | 2.57% | 1.66% |
#13
6
Prev: #19
|
4.0 |
—
|
124,529 | 52.0% |
P
S
|
364,200 | $15,536,772 | 2014 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ICLR
ICON PUB LTD CO
|
Healthcare | 2.53% | 4.86% |
#14
11
Prev: #3
|
1.0 |
—
|
-218,172 | -71.2% |
P
S
|
88,186 | $15,318,790 | 2017 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VTRS
VIATRIS INC
|
Healthcare | 2.51% | — |
#15
Prev: #—
|
4.5 |
—
|
954,299 | — |
NEW
|
954,299 | $15,154,268 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CCRN
CROSS CTRY HEAL...
|
Healthcare | 2.40% | 1.48% |
#16
7
Prev: #23
|
2.0 |
—
|
no change | no change |
P
S
|
1,098,393 | $14,509,772 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 2.12% | 1.65% |
#17
3
Prev: #20
|
1.3 |
—
|
-59,152 | -16.1% |
P
S
|
307,657 | $12,820,067 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 1.93% | 2.75% |
#18
5
Prev: #13
|
0.8 |
—
|
-57,918 | -31.0% |
P
S
|
128,656 | $11,674,245 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 1.90% | 3.17% |
#19
9
Prev: #10
|
0.8 |
—
|
-83,821 | -43.2% |
P
S
|
110,022 | $11,510,502 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 1.87% | 0.81% |
#20
19
Prev: #39
|
3.7 |
—
|
68,832 | 109.9% |
P
S
|
131,445 | $11,316,100 | 2009 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 1.86% | — |
#21
Prev: #—
|
4.2 |
—
|
18,000 | — |
NEW
|
18,000 | $11,223,720 | 2017 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 1.85% | — |
#22
Prev: #—
|
4.2 |
—
|
193,500 | — |
NEW
|
193,500 | $11,149,470 | 2015 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 1.84% | — |
#23
Prev: #—
|
4.2 |
—
|
142,500 | — |
NEW
|
142,500 | $11,147,775 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 1.81% | 1.93% |
#24
8
Prev: #16
|
0.7 |
—
|
-423,346 | -28.2% |
P
S
|
1,075,274 | $10,957,042 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 1.50% | 0.11% |
#25
37
Prev: #62
|
3.6 |
—
|
1,476,908 | 1275.6% |
P
S
|
1,592,692 | $9,046,491 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.47% | 1.33% |
#26
2
Prev: #28
|
1.1 |
—
|
-98,655 | -13.7% |
P
S
|
623,130 | $8,910,759 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYBN
CYBIN INC
|
Unknown | 1.42% | — |
#27
Prev: #—
|
4.1 |
—
|
1,300,000 | — |
NEW
|
1,300,000 | $8,593,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 1.33% | 2.93% |
#28
16
Prev: #12
|
0.5 |
—
|
-168,238 | -63.4% |
P
S
|
97,305 | $8,054,908 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 1.21% | 1.47% |
#29
5
Prev: #24
|
1.0 |
—
|
-47,967 | -2.4% |
P
S
|
1,921,872 | $7,341,551 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 1.15% | 0.96% |
#30
4
Prev: #34
|
1.0 |
—
|
38,562 | 4.0% |
P
S
|
1,003,562 | $6,944,649 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.08% | — |
#31
Prev: #—
|
3.9 |
—
|
208,500 | — |
NEW
|
208,500 | $6,517,710 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 1.02% | 1.14% |
#32
1
Prev: #33
|
0.4 |
—
|
-436,712 | -22.7% |
P
S
|
1,486,175 | $6,182,488 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.96% | 4.45% |
#33
28
Prev: #5
|
0.4 |
—
|
-310,791 | -84.0% |
P
S
|
59,254 | $5,776,080 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.93% | 1.69% |
#34
16
Prev: #18
|
0.4 |
—
|
-166,532 | -56.6% |
P
S
|
127,808 | $5,622,274 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.88% | 1.18% |
#35
3
Prev: #32
|
0.4 |
—
|
-429,104 | -44.3% |
P
S
|
539,493 | $5,297,821 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.88% | 0.93% |
#36
Prev: #36
|
0.4 |
—
|
-123,173 | -37.1% |
P
S
|
208,557 | $5,293,177 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.86% | 0.90% |
#37
Prev: #37
|
0.8 |
—
|
-12,131 | -14.1% |
P
S
|
73,952 | $5,191,430 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.81% | 0.64% |
#38
4
Prev: #42
|
1.3 |
—
|
no change | no change |
P
S
|
1,078,965 | $4,920,080 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.63% | 0.48% |
#39
8
Prev: #47
|
0.8 |
—
|
3,787 | 0.6% |
P
S
|
617,675 | $3,804,878 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.58% | 0.55% |
#40
4
Prev: #44
|
0.7 |
—
|
-442,443 | -14.4% |
P
S
|
2,634,137 | $3,529,744 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVAH
AVEANNA HEALTHC...
|
Healthcare | 0.52% | — |
#41
Prev: #—
|
3.7 |
—
|
369,036 | — |
NEW
|
369,036 | $3,162,639 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 0.45% | 0.40% |
#42
9
Prev: #51
|
0.7 |
—
|
-247,047 | -19.7% |
P
S
|
1,005,334 | $2,704,348 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.44% | 0.52% |
#43
2
Prev: #45
|
0.2 |
—
|
-40,942 | -24.8% |
P
S
|
124,168 | $2,631,120 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HIMS
CALL
HIMS & HERS HEA...
|
CALL Option | 0.43% | — |
#44
Prev: #—
|
3.7 |
—
|
75,000 | — |
NEW
|
75,000 | $2,600,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.42% | 0.32% |
#45
10
Prev: #55
|
0.7 |
—
|
-127,267 | -19.4% |
P
S
|
529,933 | $2,564,876 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SER
SERINA THERAPEU...
|
Healthcare | 0.32% | 0.28% |
#46
10
Prev: #56
|
1.1 |
—
|
no change | no change |
P
S
|
1,000,000 | $1,940,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALGS
ALIGOS THERAPEU...
|
Healthcare | 0.31% | 0.35% |
#47
6
Prev: #53
|
1.1 |
—
|
no change | no change |
P
S
|
327,237 | $1,888,157 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IBIO
IBIO INC
|
Healthcare | 0.26% | 0.25% |
#48
9
Prev: #57
|
1.1 |
—
|
no change | no change |
P
S
|
904,268 | $1,582,469 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
XILIO THERAPEUT...
|
|
Unknown | 0.24% | 0.18% |
#49
10
Prev: #59
|
1.1 |
—
|
no change | no change |
P
S
|
152,464 | $1,460,605 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AORT
ARTIVION INC
|
Healthcare | 0.18% | — |
#50
Prev: #—
|
3.6 |
—
|
48,481 | — |
NEW
|
48,481 | $1,089,368 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 93 holdings